PP
KLRS

Paloma Partners’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Paloma Partners’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,381
Closed -$23K – 1271
2024
Q2 		$23K Buy
+1,381
New +$23K ﹤0.01% 756